SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-03-022545
Filing Date
2003-10-10
Accepted
2003-10-09 21:43:57
Documents
9
Period of Report
2003-10-09
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a03-3954_18k.htm 8-K 33062
3 EX-4.1 a03-3954_1ex4d1.htm EX-4.1 924667
4 EX-4.2 a03-3954_1ex4d2.htm EX-4.2 214732
5 EX-4.3 a03-3954_1ex4d3.htm EX-4.3 128976
6 EX-10.1 a03-3954_1ex10d1.htm EX-10.1 161544
7 EX-10.2 a03-3954_1ex10d2.htm EX-10.2 146512
8 EX-10.3 a03-3954_1ex10d3.htm EX-10.3 122408
9 EX-10.4 a03-3954_1ex10d4.htm EX-10.4 32937
10 EX-10.5 a03-3954_1ex10d5.htm EX-10.5 25049
  Complete submission text file 0001104659-03-022545.txt   1792555
Mailing Address 150 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address 150 INDUSTRIAL RD SAN CARLOS CA 94070 6506313100
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 03936007
SIC: 2834 Pharmaceutical Preparations